Sensitive ASX Announcement

Fortrea to Manage IHL FDA IND Phase 2 and 3 Clinical Trial

Published: 18/07/23, 08:14am (AEST)4 pages
Incannex Healthcare Limited
IHL:ASXHealthcare

Recent IHL Announcements

Price Sensitive only